AMGN Amgen, Inc.
$414.61
Amgen, Inc. (AMGN) is expected to report earnings on November 2, 2026, after the market close. The consensus earnings estimate is $5.69 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +5.4% since its last earnings release on August 4, 2026.
Amgen Beat Expectations, Raises Guidance, but Earnings Remain In-line with Estimates
Tuesday, August 4, 2026 · 4:01 PM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 2
Monday · 4:00 PM ET
Earnings Whisper
-
vs $5.69
Rev est $9.91B
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP
$409.76
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About Amgen, Inc.
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics.
Sector
Healthcare
Industry
Biotechnology
Held By 15 ETFs, by dollar flow
- QQQ Invesco QQQ Trust
- QQQ Invesco QQQ Trust
- OEF iShares S&P 100 ETF
- OEF iShares S&P 100 ETF
- QTOP iShares Nasdaq Top 30 Stocks ETF
- QTOP iShares Nasdaq Top 30 Stocks ETF
- DIA SPDR Dow Jones Industrial Average ETF
- DIA SPDR Dow Jones Industrial Average ETF
- IYH iShares U.S. Healthcare ETF
- IYH iShares U.S. Healthcare ETF
- XLV Health Care Select Sector SPDR Fund
- XLV Health Care Select Sector SPDR Fund
- HDV iShares Core High Dividend ETF
- HDV iShares Core High Dividend ETF
- IXJ iShares Global Healthcare ETF
Charts powered in part by Lightweight Charts™ by TradingView.